FindTrial
Sign In

Hydroxydaunorubicin

DRUG2 trials

Sponsors

Hoffmann-La Roche, University of Colorado, Denver

Conditions

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Non-Hodgkin's Lymphoma, Lymphoma, Non Hodgkin, Relapsed or Refractory Diffuse Large B-Cell LymphomaPeripheral T Cell Lymphoma

Phase 1

Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas
CompletedNCT03586999
University of Colorado, DenverPeripheral T Cell Lymphoma
Start: 2018-11-07End: 2022-09-20Updated: 2024-10-29

Unknown Phase

MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma
CompletedNCT02486952
Hoffmann-La RocheLymphoma, Lymphoma, Large B-Cell, Diffuse, Non-Hodgkin's Lymphoma, Lymphoma, Non Hodgkin, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Start: 2005-08-31End: 2011-01-31Updated: 2016-02-22